Mass spectrometry-based proteomics has greatly advanced our understanding of biological processes across diverse fields, including disease and oncology. Despite this progress, the maternal-fetal interface, particularly in the context of fetal aneuploidy, remains underexplored. This study addressed this gap by performing an exploratory, label-free mass spectrometry-based proteomic analysis of maternal urine from 15 pregnancies with normal karyo-type and 9 with fetal aneuploidy.
[doi:10.25345/C57H1F09Z]
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: fetal aneuploidy ; urine proteomics ; label-free proteomics ; DatasetType:Proteomics
|
Principal Investigators: (in alphabetical order) |
Iuga Cristina-Adela, MEDFUTURE Research Center for Advanced Medicine, Romania |
| Submitting User: | ioanapralea |
| Number of Files: | |
| Total Size: | |
| Spectra: | |
| Subscribers: | |
| Owner | Reanalyses | |
|---|---|---|
| Experimental Design | ||
|
Conditions:
|
||
|
Biological Replicates:
|
||
|
Technical Replicates:
|
||
| Identification Results | ||
|
Proteins (Human, Remapped):
|
||
|
Proteins (Reported):
|
||
|
Peptides:
|
||
|
Variant Peptides:
|
||
|
PSMs:
|
||
| Quantification Results | ||
|
Differential Proteins:
|
||
|
Quantified Proteins:
|
||
| Browse Dataset Files | |
|
FTP Download Link (click to copy):
|